Nifty
Sensex
:
:
24479.05
80429.04
-30.20 (-0.12%)
-73.04 (-0.09%)

Pharmaceuticals & Drugs - Global

Rating :
69/99

BSE: 500420 | NSE: TORNTPHARM

2891.10
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  2874.70
  •  2925.00
  •  2874.70
  •  2870.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  252725
  •  7330.86
  •  3176.55
  •  1772.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 106,175.41
  • 64.10
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 109,273.79
  • 0.89%
  • 15.49

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 0.39%
  • 3.98%
  • FII
  • DII
  • Others
  • 14.22%
  • 6.45%
  • 3.71%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.71
  • 6.21
  • 8.03

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.67
  • 9.16
  • 6.71

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.23
  • 10.08
  • 28.69

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 41.68
  • 53.41
  • 57.60

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.56
  • 8.68
  • 9.45

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.26
  • 21.35
  • 22.74

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
2,859.00
2,591.00
10.34%
2,745.00
2,491.00
10.20%
2,732.00
2,491.00
9.67%
2,660.00
2,291.00
16.11%
Expenses
1,955.00
1,800.00
8.61%
1,862.00
1,764.00
5.56%
1,863.00
1,767.00
5.43%
1,835.00
1,612.00
13.83%
EBITDA
904.00
791.00
14.29%
883.00
727.00
21.46%
869.00
724.00
20.03%
825.00
679.00
21.50%
EBIDTM
31.62%
30.53%
32.17%
29.19%
31.81%
29.06%
31.02%
29.64%
Other Income
24.00
34.00
-29.41%
31.00
9.00
244.44%
-33.00
-10.00
-
26.00
16.00
62.50%
Interest
75.00
103.00
-27.18%
80.00
107.00
-25.23%
80.00
102.00
-21.57%
91.00
69.00
31.88%
Depreciation
197.00
191.00
3.14%
203.00
196.00
3.57%
213.00
193.00
10.36%
201.00
163.00
23.31%
PBT
656.00
531.00
23.54%
631.00
433.00
45.73%
631.00
419.00
50.60%
559.00
463.00
20.73%
Tax
199.00
153.00
30.07%
182.00
146.00
24.66%
188.00
127.00
48.03%
173.00
151.00
14.57%
PAT
457.00
378.00
20.90%
449.00
287.00
56.45%
443.00
292.00
51.71%
386.00
312.00
23.72%
PATM
15.98%
14.59%
16.36%
11.52%
16.22%
11.72%
14.51%
13.62%
EPS
13.50
11.17
20.86%
13.27
8.48
56.49%
13.09
8.63
51.68%
11.40
9.22
23.64%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
10,996.00
10,727.84
9,620.15
8,508.04
8,004.57
7,939.31
7,672.80
5,949.83
5,815.69
6,666.85
4,653.45
Net Sales Growth
11.48%
11.51%
13.07%
6.29%
0.82%
3.47%
28.96%
2.31%
-12.77%
43.27%
 
Cost Of Goods Sold
2,730.00
2,458.95
2,513.20
2,230.75
1,960.12
1,981.79
2,041.26
1,535.17
1,629.66
1,432.13
1,280.96
Gross Profit
8,266.00
8,268.89
7,106.95
6,277.29
6,044.45
5,957.52
5,631.54
4,414.66
4,186.03
5,234.72
3,372.49
GP Margin
75.17%
77.08%
73.88%
73.78%
75.51%
75.04%
73.40%
74.20%
71.98%
78.52%
72.47%
Total Expenditure
7,515.00
7,364.25
6,796.18
6,076.77
5,524.49
5,768.95
5,696.31
4,600.58
4,438.42
3,937.05
3,633.29
Power & Fuel Cost
-
145.20
155.28
144.19
122.94
128.19
132.46
118.77
107.98
92.59
97.41
% Of Sales
-
1.35%
1.61%
1.69%
1.54%
1.61%
1.73%
2.00%
1.86%
1.39%
2.09%
Employee Cost
-
1,984.40
1,677.69
1,526.45
1,439.62
1,429.04
1,403.79
1,135.25
993.41
842.35
841.81
% Of Sales
-
18.50%
17.44%
17.94%
17.98%
18.00%
18.30%
19.08%
17.08%
12.63%
18.09%
Manufacturing Exp.
-
570.58
570.79
591.13
550.92
544.11
558.84
457.58
502.16
353.45
345.98
% Of Sales
-
5.32%
5.93%
6.95%
6.88%
6.85%
7.28%
7.69%
8.63%
5.30%
7.43%
General & Admin Exp.
-
980.72
775.30
637.65
633.48
801.98
763.90
677.71
578.05
637.92
463.28
% Of Sales
-
9.14%
8.06%
7.49%
7.91%
10.10%
9.96%
11.39%
9.94%
9.57%
9.96%
Selling & Distn. Exp.
-
1,129.68
1,026.99
884.91
742.63
807.39
738.03
641.30
567.70
547.05
574.40
% Of Sales
-
10.53%
10.68%
10.40%
9.28%
10.17%
9.62%
10.78%
9.76%
8.21%
12.34%
Miscellaneous Exp.
-
94.72
76.93
61.69
74.78
76.45
58.03
34.80
59.46
31.56
574.40
% Of Sales
-
0.88%
0.80%
0.73%
0.93%
0.96%
0.76%
0.58%
1.02%
0.47%
0.63%
EBITDA
3,481.00
3,363.59
2,823.97
2,431.27
2,480.08
2,170.36
1,976.49
1,349.25
1,377.27
2,729.80
1,020.16
EBITDA Margin
31.66%
31.35%
29.35%
28.58%
30.98%
27.34%
25.76%
22.68%
23.68%
40.95%
21.92%
Other Income
48.00
61.97
63.22
196.56
56.91
121.30
63.62
298.84
223.30
228.80
285.55
Interest
326.00
353.56
333.44
255.06
352.94
450.71
503.75
308.48
205.56
183.98
175.16
Depreciation
814.00
808.27
706.59
662.16
657.79
654.38
617.69
408.60
306.92
237.55
190.74
PBT
2,477.00
2,263.73
1,847.16
1,710.61
1,526.26
1,186.57
918.67
931.01
1,088.09
2,537.07
939.81
Tax
742.00
695.73
601.93
448.73
274.38
161.85
125.35
252.87
154.51
610.17
188.84
Tax Rate
29.96%
29.58%
32.59%
36.60%
17.98%
13.64%
22.32%
27.16%
14.20%
26.04%
20.09%
PAT
1,735.00
1,656.38
1,245.23
777.18
1,251.88
1,024.72
436.28
678.11
933.55
1,733.24
750.94
PAT before Minority Interest
1,735.00
1,656.38
1,245.23
777.18
1,251.88
1,024.72
436.31
678.14
933.58
1,733.27
750.97
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
PAT Margin
15.78%
15.44%
12.94%
9.13%
15.64%
12.91%
5.69%
11.40%
16.05%
26.00%
16.14%
PAT Growth
36.72%
33.02%
60.22%
-37.92%
22.17%
134.88%
-35.66%
-27.36%
-46.14%
130.81%
 
EPS
51.27
48.95
36.80
22.97
36.99
30.28
12.89
20.04
27.59
51.22
22.19

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
6,856.15
6,198.07
5,952.95
5,837.17
4,823.22
4,724.35
4,622.19
4,350.13
3,494.10
2,490.56
Share Capital
169.23
169.23
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
Total Reserves
6,686.92
6,028.84
5,868.33
5,752.55
4,738.60
4,639.73
4,537.57
4,265.51
3,409.48
2,405.94
Non-Current Liabilities
2,224.05
2,822.81
2,238.15
2,924.20
3,299.15
3,861.40
4,142.42
2,303.33
1,994.65
2,504.92
Secured Loans
1,603.78
2,496.22
2,123.22
2,941.07
3,302.29
3,909.81
4,105.31
2,229.57
1,839.46
2,171.60
Unsecured Loans
0.00
0.00
0.00
0.00
1.56
3.11
6.15
11.26
10.62
13.62
Long Term Provisions
444.69
393.06
368.74
369.62
338.34
288.52
286.66
263.04
246.36
207.49
Current Liabilities
5,425.25
5,447.30
4,415.09
4,891.62
5,454.16
5,165.32
5,202.17
2,738.26
3,285.48
2,823.75
Trade Payables
2,089.32
1,678.80
1,674.44
2,066.81
2,048.81
2,096.74
2,048.24
1,749.32
2,260.22
1,827.72
Other Current Liabilities
1,130.15
1,578.41
1,365.10
1,635.36
1,860.80
1,641.26
1,151.68
687.14
822.28
446.15
Short Term Borrowings
1,637.71
1,765.07
923.04
704.40
1,090.85
934.11
1,625.60
0.00
3.32
319.07
Short Term Provisions
568.07
425.02
452.51
485.05
453.70
493.21
376.65
301.80
199.66
230.81
Total Liabilities
14,505.45
14,468.18
12,606.19
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
Net Block
8,138.11
8,121.45
6,422.65
7,064.63
7,533.12
7,747.71
7,854.68
3,688.44
2,859.08
2,832.66
Gross Block
13,484.57
12,811.62
10,728.19
10,511.53
10,334.13
9,935.43
9,449.48
4,909.80
3,793.53
3,542.93
Accumulated Depreciation
5,346.46
4,690.17
4,305.54
3,446.90
2,801.01
2,187.72
1,594.80
1,221.36
934.45
710.27
Non Current Assets
8,893.97
9,139.00
7,311.54
8,129.77
8,595.61
8,713.53
8,704.89
4,512.74
4,085.66
3,768.25
Capital Work in Progress
360.51
765.40
629.82
889.38
711.93
617.12
646.94
519.49
1,041.58
678.33
Non Current Investment
31.80
42.70
42.33
42.09
2.09
2.09
0.09
0.09
0.09
0.06
Long Term Loans & Adv.
349.34
181.04
166.55
96.84
222.19
150.58
130.96
182.32
99.66
206.92
Other Non Current Assets
14.21
28.41
50.19
36.83
126.28
196.03
72.22
122.40
85.25
50.28
Current Assets
5,611.48
5,313.72
5,164.99
5,523.22
4,980.92
5,037.54
5,262.41
4,879.47
4,689.03
4,051.41
Current Investments
141.04
156.09
183.98
139.05
0.02
351.35
492.27
803.55
779.59
297.59
Inventories
2,279.07
2,229.64
2,462.32
2,681.20
2,148.22
1,935.15
1,966.30
1,559.15
1,357.98
1,067.17
Sundry Debtors
1,844.30
1,943.82
1,632.48
1,523.37
1,649.34
1,435.71
1,253.45
950.89
1,445.09
1,587.26
Cash & Bank
839.04
571.46
403.41
603.50
666.65
816.04
867.23
893.72
647.03
567.36
Other Current Assets
508.03
246.89
331.62
512.69
516.69
499.29
683.16
672.16
459.34
532.03
Short Term Loans & Adv.
180.04
165.82
151.18
63.41
73.48
93.46
95.39
82.62
90.18
109.09
Net Current Assets
186.23
-133.58
749.90
631.60
-473.24
-127.78
60.24
2,141.21
1,403.55
1,227.66
Total Assets
14,505.45
14,452.72
12,476.53
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
3,266.08
2,368.13
1,802.99
2,005.35
1,392.91
1,798.08
894.15
1,008.84
2,742.12
810.20
PBT
2,352.11
1,847.16
1,225.91
1,526.26
1,186.57
561.66
931.01
1,088.09
2,343.44
939.81
Adjustment
993.99
937.24
1,349.95
992.84
876.21
1,418.19
606.92
430.27
552.44
337.96
Changes in Working Capital
418.08
-18.20
-351.85
-338.25
-385.83
99.39
-360.16
-125.21
423.58
-409.38
Cash after chg. in Working capital
3,764.18
2,766.20
2,224.01
2,180.85
1,676.95
2,079.24
1,177.77
1,393.15
3,319.46
868.39
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-498.10
-398.07
-421.02
-175.50
-284.04
-281.16
-283.62
-384.31
-577.34
-58.19
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-167.90
-2,415.31
-196.63
-449.42
198.61
-241.28
-4,706.95
-786.91
-837.85
-2,162.30
Net Fixed Assets
-161.25
-2,494.94
-29.00
-198.83
-378.80
-610.74
-4,245.22
-592.01
-471.42
-2,266.57
Net Investments
-102.10
6.43
-53.72
-179.03
351.33
138.83
310.79
-17.69
-484.32
-111.97
Others
95.45
73.20
-113.91
-71.56
226.08
230.63
-772.52
-177.21
117.89
216.24
Cash from Financing Activity
-2,779.64
77.36
-1,781.05
-1,650.79
-1,549.04
-1,314.45
3,417.39
-192.91
-1,435.15
1,212.25
Net Cash Inflow / Outflow
318.54
30.18
-174.69
-94.86
42.48
242.35
-395.41
29.02
469.12
-139.85
Opening Cash & Equivalents
508.53
398.40
572.56
661.82
588.76
702.04
1,067.57
1,049.86
612.38
955.05
Closing Cash & Equivalent
835.14
508.53
398.40
572.56
661.82
940.06
702.04
1,067.57
1,049.86
864.95

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
202.57
183.13
175.87
172.45
284.99
279.15
273.11
257.04
206.46
147.16
ROA
11.43%
9.20%
5.92%
9.20%
7.50%
3.15%
5.81%
10.28%
20.89%
11.71%
ROE
25.38%
20.50%
13.18%
23.49%
21.47%
9.34%
15.12%
23.80%
57.92%
34.19%
ROCE
24.28%
20.32%
14.35%
17.62%
15.28%
9.75%
13.81%
20.36%
45.63%
26.98%
Fixed Asset Turnover
1.27
1.39
1.43
1.43
1.48
1.50
1.57
1.35
1.82
1.88
Receivable days
41.38
39.99
37.86
38.92
37.65
33.78
35.74
74.66
82.76
105.19
Inventory Days
49.26
52.47
61.71
59.24
49.84
49.01
57.16
90.90
66.19
81.17
Payable days
279.66
243.50
306.08
383.19
133.47
139.05
150.99
171.27
204.35
176.11
Cash Conversion Cycle
-189.03
-151.04
-206.50
-285.04
-45.98
-56.26
-58.09
-5.72
-55.41
10.25
Total Debt/Equity
0.57
0.85
0.68
0.83
1.21
1.28
1.40
0.58
0.67
1.10
Interest Cover
7.65
6.54
5.81
5.32
3.63
2.11
4.02
6.29
13.74
6.37

News Update:


  • USFDA completes inspections at Torrent Pharmaceuticals’ Gujarat manufacturing facility
    13th Jun 2024, 10:23 AM

    The inspection was conducted from June 03, 2024 to June 12, 2024

    Read More
  • Torrent Pharmaceuticals enters into patent licensing agreement with Takeda
    5th Jun 2024, 16:21 PM

    Torrent will market Vonoprazan under its own trademark, Kabvie

    Read More
  • Torrent Pharma - Quarterly Results
    24th May 2024, 17:48 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.